2022 American Transplant Congress
Association Between Time in Therapeutic Range for Warfarin and Time in Therapeutic Range for Calcineurin Inhibitors in Patients That Received Left Ventricular Assist Devices as Bridge to Transplant
1Baylor St. Luke's Medical Center, Houston, TX, 2Baylor College of Medicine, Houston, TX
*Purpose: Medication nonadherence is a leading cause of avoidable graft failure post-transplant. The relationship between medication adherence in patients with left ventricular assist devices (LVADs)…2022 American Transplant Congress
Direct Oral Anticoagulants versus Warfarin in Adult Heart Transplant Recipients
University of California Los Angeles, Los Angeles, CA
*Purpose: Direct oral anticoagulants (DOACs) have recently transformed the field of anticoagulation, offering more predictable pharmacokinetic and pharmacodynamic characteristics when compared to traditional warfarin therapy.…2022 American Transplant Congress
Factor V Leiden Heterozygosity and Live Donor Liver Donation – A Single Center Analysis
Thomas E Starzl Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Living donor liver transplantation (LDLT) accounts for only a small percentage (< 6%) of all liver transplants performed for adult recipients in the western…2022 American Transplant Congress
New Oral Anticoagulants vs Warfarin in Kidney Transplant
*Purpose: New oral anticoagulants (NOACs) have replaced warfarin due to their similar efficacy and better safety profile in the general population (GP). The risk of…2022 American Transplant Congress
Safety and Mortality Benefit of Direct Oral Anticoagulants in Kidney Transplant
*Purpose: Direct oral anticoagulants (DOACs) are increasingly used in renal transplant recipients (RTR). We aim to identify bleeding events and all-cause mortality between DOACs and…2022 American Transplant Congress
Overexpression of Human Ectonucleoside Triphosphate Diphosphohydrolase 1 (entpd1; Hcd39) Did Not Afford Significant Protection on Porcine Endothelial Cells
*Purpose: The thromboregulatory and anti-inflammatory potential of human CD39 (hCD39) makes it a gene of interest in xenotransplantation. In porcine endothelium, CD39 activity is generally…2021 American Transplant Congress
Weathering the Cytokine Storm: Therapeutic Plasma Exchange for the Management of Severe Covid19 in Solid Organ Transplant Recipients
1Miami Transplant Institute, Miami, FL, 2Miami Trasnplant Institute, Miami, FL
*Purpose: The treatment of SARS-CoV-2 associated pneumonia in solid organ transplant recipients (SOTr) continues to be under investigation. Timely control of the cytokine release storm…2021 American Transplant Congress
Thrombotic and Hemorrhagic Complications Associated with Postoperative Anticoagulation After Pediatric Liver Transplantation
*Purpose: In order to determine the efficacy of post-liver transplant (LT) anticoagulation protocols in reducing the occurrence of arterial thrombosis (HAT) and other vascular complications…2021 American Transplant Congress
Therapeutic Enoxaparin Dosing in Lung Transplant Recipients
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Enoxaparin 1 mg/kg subcutaneously every 12 hours for therapeutic anticoagulation is known to increase rates of supratherapeutic anti-Xa levels in lung transplant recipients (LTRs).…2021 American Transplant Congress
A Retrospective Analysis of the Safety and Efficacy of Apixaban After Lung Transplant
*Purpose: Atrial arrhythmias and venous thromboembolism (VTE) are common after lung transplant. While direct acting oral anticoagulants (DOACs) have become anticoagulants of choice in atrial…
- 1
- 2
- 3
- …
- 7
- Next Page »